Cited by 2,814Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and AdiposityDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.

Mechanisms linking obesity with cardiovascular disease

Van Gaal, Luc F., Mertens, Ilse L., De Block, Christophe E.·2006·Nature

DOI 10.1038/nature05487

Open this paper in CoChat — free account

Abstract

Obesity increases the risk of cardiovascular disease and premature death. Adipose tissue releases a large number of bioactive mediators that influence not only body weight homeostasis but also insulin resistance - the core feature of type 2 diabetes - as well as alterations in lipids, blood pressure, coagulation, fibrinolysis and inflammation, leading to endothelial dysfunction and atherosclerosis. We are now beginning to understand the underlying mechanisms as well as the ways in which smoking and dyslipidaemia increase, and physical activity attenuates, the adverse effects of obesity on cardiovascular health.

Integrity signals

Registry

Crossref · 10.1038/nature05487

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
Retracted
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
Adams, K. F., Schatzkin, A. G., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R. R., Hollenbeck, A. R., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,147

Flagged first, then by citations

Show all 86 references

Sorted by citations

Items 601–700 of 1,009

Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: Distinct expression of cell-cycle- and differentiation-related genes
Rodríguez‐Acebes, S., Palacios, N., Botella-Carretero, J. I., Olea, N., Crespo, L., Peromingo, R., Gómez‐Coronado, D., Lasunción, M. A., Vázquez, C., & Martínez-Botas, J. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-61 · Cited by 58
Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?
Gaal, L. F. V., Gutkin, S. W., & Nauck, M. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0804 · Cited by 58
Leptin and adiponectin: pathophysiological role and possible therapeutic target of inflammation in ischemic stroke
Gairolla, J., Kler, R., Modi, M., & Khurana, D. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0055 · Cited by 60
The Effect of Resveratrol Supplementation on Cardio‐Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double‐Blind Controlled Trial
Abdollahi, S., Salehi‐Abargouei, A., Toupchian, O., Sheikhha, M. H., Fallahzadeh, H., Rahmanian, M., Tabatabaie, M., & Mozaffari–Khosravi, H. (2019) · Phytotherapy Research · doi:10.1002/ptr.6487 · Cited by 57
Ketogenic diets as treatment of obesity and type 2 diabetes mellitus
Casanueva, F. F., Castellana, M., Bellido, D., Trimboli, P., Castro, A. I., Sajoux, I., Rodríguez-Carnero, G., Gómez-Arbeláez, D., Crujeiras, A. B., & Olmos, M. Á. M. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09580-7 · Cited by 59
Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: Does size matter?
Phillips, C. M., & Perry, I. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.040 · Cited by 56
“Obesity represents a major public health concern as it promotes insulin resistance (IR) and is associated with increased risk of developing co-morbidities including metabolic syndrome (MetS), type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) [2,3], leading to increased risk of premature death and higher…”
Background
The Effect of Aerobic and Resistance Training and Combined Exercise Modalities on Subcutaneous Abdominal Fat: A Systematic Review and Meta-analysis of Randomized Clinical Trials
Yarizadeh, H., Eftekhar, R., Anjom-Shoae, J., Speakman, J. R., & Djafarian, K. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa090 · Cited by 68
The Edible Brown Seaweed Sargassum horneri (Turner) C. Agardh Ameliorates High-Fat Diet-Induced Obesity, Diabetes, and Hepatic Steatosis in Mice
Murakami, S., Hirazawa, C., Ohya, T., Yoshikawa, R., Mizutani, T., Ma, N., Moriyama, M., Ito, T., & Matsuzaki, C. (2021) · Nutrients · doi:10.3390/nu13020551 · Cited by 58
“Obesity has been linked to a number of serious diseases, such as type 2 diabetes, cardiovascular disease, fatty liver disease, sleep apnea, and some cancers [8,9].”
Background
Weight loss improves fasting flow-mediated vasodilation in adults: A meta-analysis of intervention studies
Joris, P. J., Zeegers, M. P., & Mensink, R. P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.056 · Cited by 56
“All these metabolic risk markers are associated with vascular endothelial dysfunction, which is characterized by a decreased arterial response to stimuli that triggers the release of vasodilators from the endothelium, and predicts longterm atherosclerotic disease progression and cardiovascular event rates [1,2].”
Background
Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients
El‐Shal, A. S., Pasha, H. F., & Rashad, N. M. (2012) · Gene · doi:10.1016/j.gene.2012.09.136 · Cited by 56
The mechanisms of Fenretinide-mediated anti-cancer activity and prevention of obesity and type-2 diabetes
Mody, N., & Mcilroy, G. D. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.012 · Cited by 56
“These include, but are not limited to, chronic diseases such as type II diabetes [2], cardiovascular disease [3] and the development of certain types of cancers [4].”
Background
Global DNA methylation levels in human adipose tissue are related to fat distribution and glucose homeostasis
Keller, M., Kralisch, S., Rohde, K., Schleinitz, D., Dietrich, A., Schön, M., Gärtner, D., Lohmann, T., Dressler, M., Tönjes, A., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3356-z · Cited by 46
“tissue may play an important role in the development of accompanying diseases [1, 2].”
Background
Loss of the Actin Remodeler Eps8 Causes Intestinal Defects and Improved Metabolic Status in Mice
Tocchetti, A., Ekalle-Soppo, C. B., Zani, F., Bianchi, F., Gagliani, M. C., Pozzi, B., Rozman, J., Elvert, R., Ehrhardt, N., Rathkolb, B., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009468 · Cited by 56
Sibutramine on Cardiovascular Outcome
Scheen, A. J. (2011) · Diabetes Care · doi:10.2337/dc11-s205 · Cited by 55
The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats
Lü, J., Ji, J., Meng, H., Wang, D., Jiang, B., Liu, L., Randell, E. W., Adeli, K., & Meng, Q. H. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-58 · Cited by 56
“Emerging evidence suggests that insulin resistance is strongly associated with the development of atherosclerosis and cardiovascular disease [1,2].”
Background
Probabilistic Networks of Blood Metabolites in Healthy Subjects As Indicators of Latent Cardiovascular Risk
Saccenti, E., Diez, M. S., Luchinat, C., Santucci, C., & Tenori, L. (2014) · Journal of Proteome Research · doi:10.1021/pr501075r · Cited by 56
The Soy Peptide Phe–Leu–Val Reduces TNFα-Induced Inflammatory Response and Insulin Resistance in Adipocytes
Kwak, S.-J., Kim, C.-S., Choi, M., Park, T., Sung, M., Yun, J. W., Yoo, H., Mine, Y., & Yu, R. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3685 · Cited by 56
Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers
Ward-Caviness, C. K., Xu, T., Aspelund, T., Thorand, B., Montrone, C., Meisinger, C., Dunger-Kaltenbach, I., Zierer, A., Yu, Z., Helgadottir, I. R., et al. (2017) · Heart · doi:10.1136/heartjnl-2016-310789 · Cited by 58
Dynapenic Abdominal Obesity Increases Mortality Risk Among English and Brazilian Older Adults: A 10-Year Follow-Up of the ELSA and SABE Studies
Alexandre, T. D. S., Scholes, S., Santos, J. L. F., Duarte, Y. A. O., & de Oliveira, C. M. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0966-4 · Cited by 56
“Central obesity is associated with visceral fat accumulation and an adverse metabolic profile (38, 39).”
Exploring the multidimensional complex systems structure of the stress response and its relation to health and sleep outcomes
Engert, V., Kok, B. E., Puhlmann, L. M. C., Stalder, T., Kirschbaum, C., Apostolakou, F., Papanastasopoulou, C., Papassotiriou, I., Pervanidou, P., Chrousos, G. P., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.023 · Cited by 57
Elevated Gamma-Glutamyltransferase Activity and Perturbed Thiol Profile Are Associated With Features of Metabolic Syndrome
Giral, P., Jacob, N., Dourmap, C., Hansel, B., Carrié, A., Bruckert, É., Girerd, X. J., & Chapman, M. J. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.157891 · Cited by 56
Drugs affecting body weight, body fat distribution, and metabolic function—mechanisms and possible therapeutic or preventive measures: an update.
Verhaegen, A. A., & Van Gaal, L. F. (2021) · Current Obesity Reports · doi:10.1007/s13679-020-00419-5 · Cited by 53
“In the non-HIV-infected population, weight gain and obesity are well-documented risk factors for diabetes and CVD, and to premature mortality [105].”
Background
Potential beneficial effect of some adipokines positively correlated with the adipose tissue content on the cardiovascular system
Sawicka, M., Janowska, J., & Chudek, J. T. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.054 · Cited by 53
Adipocyte-Targeting Type I AIE Photosensitizer for Obesity Treatment via Photodynamic Lipid Peroxidation
Lee, M. M. S., Lin, D. M., Chau, J. H. C., Yu, E. Y., Ding, D., Kwok, R. T. K., Wang, D., & Tang, B. Z. (2023) · ACS Nano · doi:10.1021/acsnano.3c03654 · Cited by 57
The emerging pleiotrophic role of adipokines in the uremic phenotype
Carrero, J. J., Cordeiro, A. C., Lindholm, B., & Stenvinkel, P. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328332fc2b · Cited by 57
Use of cannabinoid CB1 receptor antagonists for the treatment of metabolic disorders
Scheen, A. J., & Paquot, N. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.001 · Cited by 55
Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events
Azeem, H. A. E., Khalek, E.-S. A., El-Akabawy, H., Na'eim, H., Khalik, H. A., & Alfifi, A. A. (2013) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2013.07.004 · Cited by 57
“Moreover, ectopic fat deposition in visceral adipose depots and heart increases the expression of several pro-inflammatory mediators leading to local macrophage infiltration and associated systemic chronic inflammation [24,25].”
Background
Chronic intermittent hypoxia causes endothelial dysfunction in a mouse model of diet-induced obesity
Badran, M., Golbidi, S., Devlin, A. M., Ayas, N., & Laher, I. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.01.013 · Cited by 55
“Obesity promotes endothelial dysfunction through many metabolic disorders such as accumulation of adipose tissue, dyslipidemia, elevated blood pressure and diabetes, which are linked to vascular oxidative stress and inflammation [25].”
Background
The androgen receptor confers protection against diet‐induced atherosclerosis, obesity, and dyslipidemia in female mice
Fagman, J. B., Wilhelmson, A. S., Motta, B. M., Pirazzi, C., Alexanderson, C., Gendt, K. D., Verhoeven, G., Holmäng, A. B., Anesten, F., Jansson, J., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-259234 · Cited by 55
“Hypercholesterolemia is the most important risk factor for atherosclerosis and associated complications (21, 22).”
Background
Dietary Regulation of Adult Stem Cells
Mana, M., Kuo, E. Y.-S., & Yilmaz, Ö. H. (2017) · Current Stem Cell Reports · doi:10.1007/s40778-017-0072-x · Cited by 57
Effect of inactivated Bifidobacterium longum intake on obese diabetes model mice (TSOD)
Othman, M. B., & Sakamoto, K. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108792 · Cited by 58
Multimorbidity among Two Million Adults in China
Wang, X., Yao, S., Wang, M., Cao, G., Chen, Z., Huang, Z.-T., Wu, Y. Y., Han, L., Xu, B., & Hu, Y. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103395 · Cited by 57
Mimicking the Nitric Oxide‐Releasing and Glycocalyx Functions of Endothelium on Vascular Stent Surfaces
Lyu, N., Du, Z., Qiu, H., Gao, P., Yao, Q., Xiong, K., Tu, Q., Li, X., Chen, B., Wang, M., et al. (2021) · Advanced Science · doi:10.1002/advs.202101788 · Cited by 53
Triglyceride and Glucose Index and Sex Differences in Relation to Major Adverse Cardiovascular Events in Hypertensive Patients Without Diabetes
Yang, K., & Liu, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.761397 · Cited by 56
“Insulin resistance was also significantly associated with coronary artery plaque vulnerability, leading to the occurrence of acute coronary syndrome (31, 32).”
Background
Associations Between Ultra-processed Foods Consumption and Indicators of Adiposity in US Adolescents: Cross-Sectional Analysis of the 2011-2016 National Health and Nutrition Examination Survey
Neri, D. A., Steele, E. M., Khandpur, N., & Levy, R. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.01.005 · Cited by 63
Health Complications of Obesity
Yuen, M. M. A. (2023) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2023.03.006 · Cited by 58
CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance
Guo, C., Kogan, S., Amano, S. U., Wang, M., Dağdeviren, S., Friedline, R. H., Aouadi, M., Kim, J. K., & Czech, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2012 · Cited by 57
“OBESITY IS OFTEN ASSOCIATED with type 2 diabetes (14, 18), hepatic steatosis, nonalcoholic steatohepatitis (NASH) (4), cardiovascular complications (21, 42), and certain cancers (1, 44).”
Background
Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state
Victoriano, M., de Beaurepaire, R., Naour, N., Guerre-Millo, M., Quignard‐Boulangé, A., Huneau, J., Mathé, V., Tomé, D., & Hermier, D. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.060 · Cited by 54
Aged garlic extract suppresses inflammation in apolipoprotein E‐knockout mice
Morihara, N., Hino, A., Miki, S., Takashima, M., & Suzuki, J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700308 · Cited by 54
Mucosal‐associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders
Touch, S., Assmann, K. E., Aron‐Wisnewsky, J., Marquet, F., Rouault, C., Fradet, M., Mosbah, H., Isnard, R., Helft, G., Lehuen, A., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800052rr · Cited by 60
Diet and lifestyle in managing postmenopausal obesity
Dubnov‐Raz, G., Pines, A., & Berry, E. M. (2007) · Climacteric · doi:10.1080/13697130701586428 · Cited by 53
Nonlinear Relationship Between Chinese Visceral Adiposity Index and New-Onset Myocardial Infarction in Patients with Hypertension and Obstructive Sleep Apnoea: Insights from a Cohort Study
Cai, X., Li, N., Hu, J., Wen, W., Yao, X., Zhu, Q., Heizhati, M., Hong, J., Sun, L., Tuerxun, G., et al. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s351238 · Cited by 53
“Visceral obesity is considered to be a more prominent risk factor for CVD than subcutaneous fat.(13,14) Although several imaging methods, including computed tomography, magnetic resonance imaging, dual-energy X-ray absorptiometry, and dual bioelectricity impedance analysis, can be used to accurately assess the fat dis…”
Background
Insulin resistance drives cognitive impairment in hypertensive pre-diabetic frail elders: the CENTENNIAL study
Mone, P., Gennaro, S. D., Moriello, D., Frullone, S., D’Amelio, R., Ferrante, M. N. V., Marro, A., & Santulli, G. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad173 · Cited by 53
Factor XIII-A transglutaminase acts as a switch between preadipocyte proliferation and differentiation
Myneni, V. D., Hitomi, K., & Kaartinen, M. T. (2014) · Blood · doi:10.1182/blood-2013-12-543223 · Cited by 53
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients
Derosa, G., Maffioli, P., Ferrari, I., D’Angelo, A., Fogari, E., Palumbo, I., Randazzo, S., & Cicero, A. F. G. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-049 · Cited by 53
Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
Gaal, L. V., & Dirinck, E. L. (2016) · Diabetes Care · doi:10.2337/dcs15-3016 · Cited by 55
“Obesitydin particular, abdominal obesitydis a major driver in the development of diabetes and cardiovascular disease (1,2).”
Background
Sarcopenia in patients with non‐alcoholic fatty liver disease: is it a clinically significant entity?
Fré, C. H. D., Fré, M. A. D., Kwanten, W. J., Op de Beeck, B., Gaal, L. F. V., & Francque, S. (2018) · Obesity Reviews · doi:10.1111/obr.12776 · Cited by 53
“The prevalence of obesity is rising worldwide and with the increasing prevalence amongst young adults and children, estimated at 28% and 47%, respectively, obesity will be one of the future major health problems (7,8).”
Background
The Risk of Myocardial Infarction and Ischemic Stroke According to Waist Circumference in 21,749,261 Korean Adults: A Nationwide Population-Based Study
Cho, J. H., Rhee, E., Park, S. E., Kwon, H., Jung, J., Han, K., Park, Y. G., Park, H. S., Kim, Y., Yoo, S. J., et al. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0039 · Cited by 53
The potential of TEMPO-oxidized cellulose nanofibrils as rheology modifiers in food systems
Aaen, R., Simon, S., Brodin, F. W., & Syverud, K. (2019) · Cellulose · doi:10.1007/s10570-019-02448-3 · Cited by 54
Association between Lysosomal Dysfunction and Obesity-Related Pathology: A Key Knowledge to Prevent Metabolic Syndrome
Mizunoe, Y., Kobayashi, M., Tagawa, R., Nakagawa, Y., Shimano, H., & Higami, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153688 · Cited by 56
Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial
Parker, H. M., Cohn, J. S., O'Connor, H. T., Garg, M. L., Caterson, I. D., George, J., & Johnson, N. A. (2019) · Nutrients · doi:10.3390/nu11020475 · Cited by 52
“fat in particular, predisposes individuals to type 2 diabetes, hypertension, and dyslipidemia [2].”
Background
Trajectories of body mass index in adulthood and all-cause and cause-specific mortality in the Melbourne Collaborative Cohort Study
Yang, Y., Dugué, P., Lynch, B. M., Hodge, A. M., Karahalios, A., MacInnis, R. J., Milne, R. L., Giles, G. G., & English, D. R. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030078 · Cited by 52
Oral administration of omega-7 palmitoleic acid induces satiety and the release of appetite-related hormones in male rats
Yang, Z., Takeo, J., & Katayama, M. (2013) · Appetite · doi:10.1016/j.appet.2013.01.009 · Cited by 52
l-Leucine and NO-mediated cardiovascular function
Yang, Y., Wu, Z., Meininger, C. J., & Wu, G. (2014) · Amino Acids · doi:10.1007/s00726-014-1904-y · Cited by 53
Chronic Obstructive Pulmonary Disease with Lung Cancer and/or Cardiovascular Disease
Rodriguez‐Roisin, R., & Soriano, J. B. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200807-075th · Cited by 54
Body mass index, physical activity, and survival after endometrial cancer diagnosis: Results from the Women's Health Initiative
Arem, H. E., Chlebowski, R. T., Stefanick, M. L., Anderson, G. L., Wactawski‐Wende, J., Sims, S. T., Gunter, M. J., & Irwin, M. L. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.10.029 · Cited by 52
“It is well established that obesity is associated with a higher risk of death from cardiovascular disease [24, 35], and that this risk can be attenuated through physical activity and weight loss [36].”
Background
Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: a double blind, placebo controlled randomized trial
Verhoeven, V., der Auwera, A. V., Gaal, L. V., Remmen, R., Apers, S., Stalpaert, M., Wens, J., & Hermans, N. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0576-9 · Cited by 53
“Metabolic syndrome comprises a broad clinical spectrum and the definition and concept are matter of debate; however, the clustering of dyslipidemia, dysglycemia, intra-abdominal fat accumulation and hypertension unequivocally leads to an increased risk of developing CVD and diabetes [5].”
Background
IKKβ Is Essential for Adipocyte Survival and Adaptive Adipose Remodeling in Obesity
Park, S., Liu, Z., Sui, Y., Helsley, R. N., Zhu, B., Powell, D. K., Kern, P. A., & Zhou, C. (2016) · Diabetes · doi:10.2337/db15-1156 · Cited by 52
Dynamics of Organohalogenated Contaminants in Human Serum from Obese Individuals during One Year of Weight Loss Treatment
Dirtu, A. C., Dirinck, E. L., Malarvannan, G., Neels, H. M., Gaal, L. V., Jorens, P. G., & Covaci, A. (2013) · Environmental Science & Technology · doi:10.1021/es400657t · Cited by 51
ULK1 prevents cardiac dysfunction in obesity through autophagy-meditated regulation of lipid metabolism
An, M., Ryu, D., Park, J.-W., Choi, J. H., Park, E., Lee, K. E., Woo, M., & Kim, M. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx064 · Cited by 53
Ratio of visceral‐to‐subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes
Fukuda, T., Bouchi, R., Takeuchi, T., Nakano, Y., Murakami, M., Minami, I., Izumiyama, H., Hashimoto, K., Yoshimoto, T., & Ogawa, Y. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12713 · Cited by 52
Prediction of Adulthood Obesity Using Genetic and Childhood Clinical Risk Factors in the Cardiovascular Risk in Young Finns Study
Seyednasrollah, F. S., Mäkelä, J., Pitkänen, N., Juonala, M., Hutri‐Kähönen, N., Lehtimäki, T. J., Viikari, J. S. A., Kelly, T. N., Li, C., Bazzano, L., et al. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001554 · Cited by 60
A Metabolic Obesity Profile Is Associated With Decreased Gray Matter Volume in Cognitively Healthy Older Adults
Beyer, F., Masouleh, S. K., Kratzsch, J., Schroeter, M. L., Röhr, S., Riedel-Heller, S. G., Villringer, A., & Witte, A. V. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00202 · Cited by 49
“The metabolic profile of the first LV represents common metabolic dysregulations in obesity (Van Gaal et al., 2006).”
Background
Differential Mitochondrial Gene Expression in Adipose Tissue Following Weight Loss Induced by Diet or Bariatric Surgery
van der Kolk, B. W., Muniandy, M., Kamińska, D., Alvarez, M., Ko, A., Miao, Z., Valsesia, A., Langin, D., Vaittinen, M., Pääkkönen, M., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab072 · Cited by 52
“The study criteria were (1) a BMI ≥ 40 kg/m(2), or BMI ≥ 35 kg/m(2) with an obesityassociated comorbidity; (2) a failure of traditional obesity treatments; and (3) no other surgical contraindications.”
Background
Role of the Endocannabinoid System in the Adipose Tissue with Focus on Energy Metabolism
Rakotoarivelo, V., Sihag, J., & Flamand, N. (2021) · Cells · doi:10.3390/cells10061279 · Cited by 55
“This is because obesity is significantly associated with several chronic diseases such as type 2 diabetes [12], cardiometabolic disorders [13] and some types of cancer [14].”
Background
The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
Badawi, A. F., DaCosta, Arora, Garcia-Bailo, Karmali, M. A., & El‐Sohemy, A. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s35115 · Cited by 52
“6 Adipose tissue also secretes a variety of cytokines, such as the proinflammatory Tumor necrosis factor (TNF-a ) and Interleukin-6 (IL-6), 5 which can activate signal transduction cascades that inhibit insulin action.”
Body Mass Index Regulates Hypogonadism-Associated CV Risk: Results from a Cohort of Subjects with Erectile Dysfunction
Corona, G., Rastrelli, G., Monami, M., Melani, C., Balzi, D., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02292.x · Cited by 51
Oral administration of the milk casein-derived tripeptide Val-Pro-Pro attenuates high-fat diet-induced adipose tissue inflammation in mice
Aihara, K., Osaka, M., & Yoshida, M. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001147 · Cited by 51
C57Bl/6 N mice on a western diet display reduced intestinal and hepatic cholesterol levels despite a plasma hypercholesterolemia
Desmarchelier, C., Dahlhoff, C., Keller, S., Sailer, M., Jahreis, G., & Daniel, H. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-84 · Cited by 51
“Dyslipidemia is characterized by elevated plasma levels of triacylglycerides (TG), very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), total cholesterol and decreased levels of high-density lipoprotein (HDL) [4].”
BackgroundInfluential
Potential health benefits of Indian spices in the symptoms of the metabolic syndrome: a review.
Iyer, A., Panchal, S. K., Poudyal, H., & Brown, L. (2009) · PubMed · Cited by 51
Fat depot‐specific expression of H OX C 9 and H OX C 10 may contribute to adverse fat distribution and related metabolic traits
Brune, J. E., Kern, M., Kunath, A., Flehmig, G., Schön, M. R., Lohmann, T., Dreßler, M., Dietrich, A., Faßhauer, M., Kovacs, P. L., et al. (2015) · Obesity · doi:10.1002/oby.21317 · Cited by 51
Glycemic variability predicts inflammation in adolescents with type 1 diabetes
Hoffman, R. P., Dye, A. S., Huang, H., & Bauer, J. A. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0139 · Cited by 51
Serum Metabolomics of Activity Energy Expenditure and its Relation to Metabolic Syndrome and Obesity
Palmnäs, M. S. A., Kopciuk, K. A., Shaykhutdinov, R. A., Robson, P. J., Mignault, D., RABASA-LHORET, R. P. R., Vogel, H. J., & Csizmadi, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-21585-6 · Cited by 53
Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Göttingen minipigs
Renner, S., Blutke, A., Dobenecker, B., Dhom, G., Müller, T. D., Finan, B., Clemmensen, C., Bernau, M., Novak, I., Rathkolb, B., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.015 · Cited by 53
“Obese individuals are susceptible to co-morbidities such as type 2 diabetes mellitus [5], nonalcoholic fatty liver disease (NAFLD) and steatohepatitis [6], asthma [7], certain cancers [8], and cardiovascular [9] and neurodegenerative diseases [10].”
Background
Convergence of non-communicable diseases and tuberculosis: a two-way street?
Magee, M. J., Salindri, A. D., Gujral, U. P., Auld, S. C., Bao, J., HAW, J. S., Lin, H.-H., & Kornfeld, H. (2018) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.18.0045 · Cited by 53
Proteomics approach to identify serum biomarkers associated with the progression of diabetes in Korean patients with abdominal obesity
Kim, S. W., Choi, J., Yun, J. W., Chung, I., Cho, H., Song, S.-E., Im, S., & Song, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222032 · Cited by 51
The evolving obesity challenge: targeting the vagus nerve and the inflammatory reflex in the response
Pavlov, V. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107794 · Cited by 50
Impact of Body Mass Index on Biochemical Recurrence Rates After Radical Prostatectomy: An Analysis Utilizing Propensity Score Matching
Magheli, A., Rais‐Bahrami, S., Trock, B. J., Humphreys, E. B., Partin, A. W., Han, M., & Gonzalgo, M. L. (2008) · Urology · doi:10.1016/j.urology.2008.01.052 · Cited by 51
Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals
Slusher, A. L., Whitehurst, M., Zoeller, R. F., Mock, J. T., Maharaj, M., & Huang, C.-J. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.06.002 · Cited by 50
“Circulating FGF21 concentrations are positively associated with body mass index (BMI) [7] and elevated in patients with T2D [8], potentially as a compensatory mechanism to mediate obesity related metabolic and inflammatory insult [9,10].”
BackgroundInfluential
Individual contributions of visceral fat and total body fat to subclinical atherosclerosis: The NEO study
Gast, K. B., den Heijer, M., Smit, J. W. A., Widya, R. L., Lamb, H. J., Roos, A., Jukema, J. W., Rosendaal, F. R., & de Mutsert, R. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.026 · Cited by 51
Adipocyte P2X7 receptors expression: A role in modulating inflammatory response in subjects with metabolic syndrome?
Madec, S., Rossi, C., Chiarugi, M., Santini, E., Salvati, A., Ferrannini, E., & Solini, A. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.012 · Cited by 50
Overweight, obesity, and outcomes: fat mass and beyond
Gaal, L. F. V., & Maggioni, A. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62076-0 · Cited by 50
Effects of Whole Body Vibration Plus Diet on Insulin-Resistance in Middle-Aged Obese Subjects
Bellia, A., Sallì, M., Lombardo, M., D’Adamo, M., Guglielmi, V., Tirabasso, C., Giordani, L., Federici, M., Lauro, D., Foti, C., et al. (2013) · International Journal of Sports Medicine · doi:10.1055/s-0033-1354358 · Cited by 51
The Relationship Between Inflammation, Dyslipidemia and Physical Exercise: From the Epidemiological to Molecular Approach
Lira, F. S., Neto, J. C. R., Antunes, B. M., & Fernandes, R. A. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666141122210135 · Cited by 50
“Obesity affects the high prevalence of dyslipidemia in developed and developing nations [6-8].”
Background
Interferon Regulatory Factor Signalings in Cardiometabolic Diseases
Zhang, X., Zhang, P., & Li, H. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.04898 · Cited by 51
A Long-Term High-Fat/High-Sucrose Diet Promotes Kidney Lipid Deposition and Causes Apoptosis and Glomerular Hypertrophy in Bama Minipigs
Li, L., Zhao, Z., Xia, J., Xin, L., Chen, Y., Yang, S., & Li, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142884 · Cited by 50
“The deposition of excessive amounts of lipids in the kidney results in lipotoxicity, which leads to inflammatory responses and oxidative stress [35, 36].”
Background
SIRT3 Deficiency Induces Endothelial Insulin Resistance and Blunts Endothelial-Dependent Vasorelaxation in Mice and Human with Obesity
Yang, L., Zhang, J., Xing, W., Zhang, X., Xu, J., Zhang, H., Chen, L., Ning, X., Ji, G., Li, J., et al. (2016) · Scientific Reports · doi:10.1038/srep23366 · Cited by 50
Sex differences in fat distribution influence the association between BMI and arterial stiffness
van den Munckhof, I., Holewijn, S., Graaf, J. D., & Rutten, J. H. W. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001297 · Cited by 50
Lifestyle and Dietary Determinants of Serum Apolipoprotein A1 and Apolipoprotein B Concentrations: Cross-Sectional Analyses within a Swedish Cohort of 24,984 Individuals
Frondelius, K., Borg, M., Ericson, U., Borné, Y., Melander, O., & Sonestedt, E. (2017) · Nutrients · doi:10.3390/nu9030211 · Cited by 50
“Several lifestyle and dietary factors play important roles in CVD prevention [10].”
BackgroundInfluential
Dynapenic obesity as an associated factor to lipid and glucose metabolism disorders and metabolic syndrome in older adults – Findings from SABE Study
Alexandre, T. D. S., Aubertin‐Leheudre, M., Carvalho, L. P., Máximo, R. D. O., Corona, L. P., de Brito, T. R. P., Nunes, D. P., Santos, J. L. F., Duarte, Y. A. D. O., & Lebrão, M. L. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.009 · Cited by 50
An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals
Détaille, D., Pasdois, P., Sémont, A., Santos, P. D. D., & Diolez, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216385 · Cited by 53
Platelet mitochondrial DNA methylation predicts future cardiovascular outcome in adults with overweight and obesity
Corsi, S., Iodice, S., Vigna, L., Çayır, A., Mathers, J. C., Bollati, V., & Byun, H. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00825-5 · Cited by 52
Obesity and Gray Matter Volume Assessed by Neuroimaging: A Systematic Review
Fernández‐Andújar, M., Morales-García, E., & García‐Casares, N. (2021) · Brain Sciences · doi:10.3390/brainsci11080999 · Cited by 56
“In this sense, an increased accumulation of body fat (mainly in the abdominal cavity) can induce metabolic alterations such as insulin resistance, dyslipidemia, increases in oxidative stress or lowgrade chronic inflammation [23].”
Background
Covalent inhibition of endoplasmic reticulum chaperone GRP78 disconnects the transduction of ER stress signals to inflammation and lipid accumulation in diet-induced obese mice
Luo, D., Fan, N., Zhang, X., Ngo, F. Y., Zhao, J., Zhao, W., Huang, M., Ding, L., Wang, Y., & Rong, J. (2022) · eLife · doi:10.7554/elife.72182 · Cited by 50
Mapping of the Fibroblast Growth Factors in Human White Adipose Tissue
Mejhert, N., Galitzky, J., Pettersson, A., Bambace, C., Blomqvist, L., Bouloumié, A., Frayn, K. N., Dahlman, I. A., Arner, P., & Rydén, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2049 · Cited by 50
New concepts for body shape-related cardiovascular risk: role of fat distribution and adipose tissue function.
Blüher, M., & Laufs, U. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz411 · Cited by 40
Molecular Mechanisms of Vaspin Action – From Adipose Tissue to Skin and Bone, from Blood Vessels to the Brain
Weiner, J., Zieger, K., Pippel, J., & Heiker, J. T. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_241 · Cited by 49
Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
Hashiesh, H. M., Sharma, C., Goyal, S. N., Jha, N. K., & Ojha, S. K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.702675 · Cited by 52
Association between indoor air pollutant exposure and blood pressure and heart rate in subjects according to body mass index
Jung, C., Su, H.-J. J., & Liang, H.-H. (2015) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2015.08.158 · Cited by 51
Silence of TRIB3 Suppresses Atherosclerosis and Stabilizes Plaques in Diabetic ApoE−/−/LDL Receptor−/− Mice
Wang, Z., Shang, Y., Zhang, S., Zhong, M., Wang, X.-P., Deng, J., Pan, J., Zhang, Y., & Zhang, W. (2012) · Diabetes · doi:10.2337/db11-0518 · Cited by 49

Authors: Van Gaal, L. F., Mertens, I. L., & De Block, C. E.
Affiliations: University of Antwerp (BE)
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2006-12
Volume: 444
Issue: 7121
Pages: 875-880
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature05487
OpenAlex: W1964607854
Cited by: 2,814
References: 86
Citations by year: 2026: 64 · 2025: 97 · 2024: 126 · 2023: 137 · 2022: 151 · 2021: 172 · 2020: 179 · 2019: 204 · 2018: 172 · 2017: 173 · 2016: 168 · 2015: 193 · 2014: 194 · 2013: 152 · 2012: 128
FWCI: 11.30
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: obesity, cardiovascular disease, adipose tissue, adipokines, insulin resistance, type 2 diabetes, dyslipidemia, blood pressure, coagulation, fibrinolysis, inflammation, endothelial dysfunction, atherosclerosis, smoking, physical activity, premature mortality
MeSH terms: Cardiovascular Diseases, Endothelium, Vascular, Humans, Insulin Resistance, Obesity, Oxidative Stress, Adiposity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mechanisms linking obesity with cardiovascular disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks